Close

Analyst Ratings for Fate Therapeutics (FATE)

FATE Rating Summary

FATE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on FATE
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $73.82 (+250.8%) * Over Last 12-Mos
Rating Score: 8.2 / 10   Percentile Rank: 84%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/28/2022 Needham & Company Gil Blum New Coverage Hold
(N/A)
N/A
(N/A)
33.17
(21.04)
-36.57% Details
7/11/2022 BMO Capital Etzer Darout Upgrade Outperform
(Market Perform)
47.00
(N/A)
30.01
(21.04)
-29.89% Details
Like FATE Ratings? Also take a look at GRTS, LPTX, AUTL, RCUS

FATE Ratings News